Comparison between Tremfya vs Skyrizi
| Parameter | Tremfya | Skyrizi |
|---|---|---|
| Class | IL-23 inhibitor | IL-23 inhibitor |
| Mechanism | IL-23 blockade | IL-23 blockade |
| Onset | Gradual | Gradual |
| Monitoring | None | None |
| Dosing | SC | SC |
| Half-life | ~18 days | ~28 days |
| Reversal Agent | None | None |
| Bleeding Risk | Low | Low |
| Indications | Psoriasis | Psoriasis |
| Renal Use | Caution | Caution |
| Pregnancy Use | Avoid | Avoid |
| Drug Interactions | Low | Low |
| Adherence Sensitivity | Moderate | Moderate |
| Best Use Case | Effective IL-23 | Longer interval |
| Cost | High | High |
| Monitoring Burden | Low | Low |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | Moderate | High |
| Overall Verdict | Effective | Longer dosing |
| Food Interactions | None | None |